Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 3
2014 3
2015 2
2017 2
2018 1
2019 1
2021 2
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Immunological and virological response to initial antiretroviral therapy among older people living with HIV in the Canadian Observational Cohort (CANOC).
Zhabokritsky A, Szadkowski L, Burchell AN, Cooper C, Hogg RS, Hull M, Kelly DV, Klein M, Loutfy M, McClean A, Montaner J, Walmsley SL; Canadian Observational Cohort (CANOC) Collaboration. Zhabokritsky A, et al. HIV Med. 2021 Sep;22(8):759-769. doi: 10.1111/hiv.13125. Epub 2021 Jun 1. HIV Med. 2021. PMID: 34075683
Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada?
Rana U, Driedger M, Sereda P, Pan S, Ding E, Wong A, Walmsley S, Klein M, Kelly D, Loutfy M, Thomas R, Sanche S, Kroch A, Machouf N, Roy-Gagnon MH, Hogg R, Cooper CL; Canadian Observational Cohort (CANOC) Collaboration. Rana U, et al. BMC Infect Dis. 2019 Nov 21;19(1):982. doi: 10.1186/s12879-019-4617-8. BMC Infect Dis. 2019. PMID: 31752729 Free PMC article.
Factors associated with the frequency of monitoring of liver enzymes, renal function and lipid laboratory markers among individuals initiating combination antiretroviral therapy: a cohort study.
Gillis J, Bayoumi AM, Burchell AN, Cooper C, Klein MB, Loutfy M, Machouf N, Montaner JS, Tsoukas C, Hogg RS, Raboud J; Canadian Observational Cohort (CANOC) collaboration. Gillis J, et al. BMC Infect Dis. 2015 Oct 26;15:453. doi: 10.1186/s12879-015-1206-3. BMC Infect Dis. 2015. PMID: 26496954 Free PMC article.
Impact of the Data Collection on Adverse Events of Anti-HIV Drugs cohort study on abacavir prescription among treatment-naive, HIV-infected patients in Canada.
Antoniou T, Gillis J, Loutfy MR, Cooper C, Hogg RS, Klein MB, Machouf N, Montaner JS, Rourke SB, Tsoukas C, Raboud JM; Canadian Observational Cohort (CANOC) collaboration. Antoniou T, et al. J Int Assoc Provid AIDS Care. 2014 Mar-Apr;13(2):153-9. doi: 10.1177/2325957413495565. Epub 2013 Jul 25. J Int Assoc Provid AIDS Care. 2014. PMID: 23887923 Free article.
Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients.
Antoniou T, Szadkowski L, Walmsley S, Cooper C, Burchell AN, Bayoumi AM, Montaner JS, Loutfy M, Klein MB, Machouf N, Tsoukas C, Wong A, Hogg RS, Raboud J; Canadian Observational Cohort (CANOC) collaboration. Antoniou T, et al. BMC Infect Dis. 2017 Apr 11;17(1):266. doi: 10.1186/s12879-017-2379-8. BMC Infect Dis. 2017. PMID: 28399819 Free PMC article.
Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.
Rossi C, Raboud J, Walmsley S, Cooper C, Antoniou T, Burchell AN, Hull M, Chia J, Hogg RS, Moodie EE, Klein MB; Canadian Observational Cohort (CANOC) Collaboration. Rossi C, et al. BMC Infect Dis. 2017 Apr 4;17(1):246. doi: 10.1186/s12879-017-2350-8. BMC Infect Dis. 2017. PMID: 28376824 Free PMC article.
12 results